Canada - English - Health Canada

beigene switzerland gmbh - zanubrutinib - capsule - 80mg - zanubrutinib 80mg - antineoplastic agents

Singapore - English - HSA (Health Sciences Authority)

beigene singapore pte. ltd. - zanubrutinib - capsule - zanubrutinib 80mg

European Union - English - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastic agents - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy.brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

New Zealand - English - Medsafe (Medicines Safety Authority)

beigene nz unlimited - zanubrutinib 80mg - capsule - 80 mg - active: zanubrutinib 80mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin magnesium stearate microcrystalline cellulose opacode black s-1-277002 sodium laurilsulfate titanium dioxide - waldenstrom's macroglobulinaemia (wm) brukinsa is indicated for the treatment of adult patients with waldenstr?m's macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.